Aging Clinical and Experimental Research

, Volume 12, Issue 3, pp 234–239 | Cite as

Psychotropic drug use, falls and hip fracture in the elderly

  • M. Schwab
  • F. Röder
  • T. Aleker
  • S. Ammon
  • K-P. Thon
  • M. Eichelbaum
  • U. Klotz
Short Communication


The use of benzodiazepines (BZD) or other psychotropic agents is an established risk factor for falls and hip fractures. The evidence supporting this association has been based solely on history and/or prescription data. In a case-control study we monitored the intake of BZD, tricyclic antidepressants (TCA) and barbiturates in patients with hip fracture by serum analysis, and compared this measurement with drug history and prescription records. The serum was BZD positive in 41% of 82 community-dwelling patients; an equivalent by history and/or prescription records, however, was detected in only 18% (p>0.0001). In contrast, in 82 age- and gender-matched community-dwelling control patients, there was only a minor discrepancy (3%) in BZD use between anamnestic (N=19) and analytical (N=21) data. In 23 patients admitted from nursing homes, a similar trend was visible (39% serum positive for BZD vs 26% by drug history). Barbiturate use (N=2) could be neglected, and TCA intake was minor (N=7); in each case both assessments were in accordance. In conclusion, in patients with hip fracture, BZD use is substantially more frequent than reported and previously assumed, pointing to an underestimated risk factor for this injury.

Key words

Antidepressants benzodiazepines drug screening falls hip fracture 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Asplund R.: Sleep disorders in the elderly. Drugs Aging 14: 91–103, 1999.PubMedCrossRefGoogle Scholar
  2. 2.
    Schjøtt J., Opedal K., Rutledal J.E.: A survey of hypnotic use in geriatric institutions in Sogn og Fjordane, Norway. Aging Clin. Exp. Res. 11: 50–55, 1999.Google Scholar
  3. 3.
    Kirby M., Denihan A., Bruce I., Radic A., Coakley D., Lawlor B.A.: Benzodiazepine use among the elderly in the community. Int. J. Geriatr. Psychiatry 14: 280–284, 1999.PubMedCrossRefGoogle Scholar
  4. 4.
    Folks D.G., Burke W.J.: Psychotherapeutic agents in older adults. Sedative hypnotics and sleep. Clin. Geriatr. Med. 14: 67–86, 1998.PubMedGoogle Scholar
  5. 5.
    Fraser A.D.: Use and abuse of the benzodiazepines. Ther. Drug Monit. 20: 481–489, 1998.PubMedCrossRefGoogle Scholar
  6. 6.
    Hanlon J.T., Horner R.D., Schmader K.E., Fillenbaum G.G., Lewis I.K., Wall W.E. Jr, Landerman L.R., Pieper C.F., Blazer D.G., Cohen H.J.: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin. Pharmacol. Ther. 64: 684–692, 1998.PubMedCrossRefGoogle Scholar
  7. 7.
    Wancata J., Benda N., Meise U., Muller C.: Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacol. 134: 115–120, 1997.CrossRefGoogle Scholar
  8. 8.
    Monane M., Glynn R.J., Avorn J.: The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin. Pharmacol. Ther. 59: 83–92, 1996.PubMedCrossRefGoogle Scholar
  9. 9.
    Olfson M., Pincus H.A.: Use of benzodiazepines in the community. Arch. Intern. Med. 154: 1235–1240, 1994.PubMedCrossRefGoogle Scholar
  10. 10.
    Petursson H.: Rational use of anxiolytic/sedative drugs. Drugs 25: 514–528, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Ashton H.: Guidelines for the rational use of benzodiazepines. When and how to use. Drugs 38: 25–40, 1994.Google Scholar
  12. 12.
    Rickels K., Case G.W., Winokur A., Swenson C.: Long-term benzodiazepine therapy: benefits and risks. Psychopharmacol. Bull. 20: 608–615, 1984.PubMedGoogle Scholar
  13. 13.
    Uhlenhuth E.H., De Wit H., Balter M.B., Johanson C.E., Mellinger G.D.: Risks and benefits of long-term benzodiazepine use. J. Clin. Psychopharmacol. 8: 161–167, 1988.PubMedCrossRefGoogle Scholar
  14. 14.
    Grad R.M.: Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. J. Fam. Pract. 41: 473–481, 1995.PubMedGoogle Scholar
  15. 15.
    Prudham D., Evans J.G.: Factors associated with falls in the elderly: a community study. Age Ageing 10: 141–146, 1981.PubMedCrossRefGoogle Scholar
  16. 16.
    Ray W.A., Griffin M.R., Schaffner W., Baugh D.K., Melton L.J.: Psychotropic drug use and the risk of hip fracture. N. Engl. J. Med. 316: 363–369, 1987.PubMedCrossRefGoogle Scholar
  17. 17.
    Taggart H.M.: Do drugs affect the risk of hip fracture in elderly women? J. Am. Geriatr. Soc. 11: 1006–1010, 1988.Google Scholar
  18. 18.
    Sorock G.S., Shimkin E.E.: Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch. Intern. Med. 148: 2441–2444, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Ray W.A., Griffin M.R., Downey W.: Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262: 3303–3307, 1989.PubMedCrossRefGoogle Scholar
  20. 20.
    Campbell A.J.: Drug treatment as a cause of falls in old age. A review of the offending agents. Drugs Aging 1: 289–302, 1991.PubMedCrossRefGoogle Scholar
  21. 21.
    Cumming R.G., Miller J.P., Kelsey J.L., Davis P., Arfken C.L., Birge S.J., Peck W.A.: Medications and multiple falls in elderly people: the St. Louis OASIS study. Age Ageing 20: 455–461, 1991.PubMedCrossRefGoogle Scholar
  22. 22.
    Ryynanen O.P., Kivela S.L., Honkanen R., Laippala P., Saano V.: Medications and chronic diseases as risk factors for falling injuries in the elderly. Scand. J. Soc. Med. 21: 264–271, 1993.PubMedGoogle Scholar
  23. 23.
    Cumming R.G., Klineberg R.J.: Psychotropics, thiazide diuretics and hip fractures in the elderly. Med. J. Aust. 158: 414–417, 1993.PubMedGoogle Scholar
  24. 24.
    Tinetti M.E., Liu W.L., Claus E.B.: Predictors and prognosis of inability to get up after falls among elderly persons. JAMA 269: 65–70, 1993.PubMedCrossRefGoogle Scholar
  25. 25.
    Rubenstein L.Z., Josephson K.R., Robbins A.S.: Falls in the nursing home. Ann. Intern. Med. 121: 442–451, 1994.PubMedCrossRefGoogle Scholar
  26. 26.
    Yip Y.B., Cumming R.G.: The association between medications and falls in Australian nursing-home residents. Med. J. Aust. 160: 14–18, 1994.PubMedGoogle Scholar
  27. 27.
    Gales B.J., Menard S.M.: Relationship between the administration of selected medications and falls in hospitalized elderly patients. Ann. Pharmacother. 29: 354–358, 1995.PubMedGoogle Scholar
  28. 28.
    Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., Ensrud K.E., Cauley J., Black D., Vogt T.M.: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 332: 767–773, 1995.PubMedCrossRefGoogle Scholar
  29. 29.
    Lord S.R., Anstey K.J., Williams P., Ward J.A.: Psychoactive medication use, sensori-motor function and falls in older women. Br. J. Clin. Pharmacol. 39: 227–234, 1995.PubMedCrossRefGoogle Scholar
  30. 30.
    Luukinen H., Koski K., Laippala P., Kivela S.L.: Predictors for recurrent falls among the home-dwelling elderly. Scand. J. Prim. Health Care 13: 294–299, 1995.PubMedCrossRefGoogle Scholar
  31. 31.
    Thapa P.B., Gideon P., Fought R.L., Ray W.A.: Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am. J. Epidemiol. 142: 202–211, 1995.PubMedGoogle Scholar
  32. 32.
    Herings R.M., Stricker B.H., de Boer A., Bakker A., Sturmans F.: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch. Intern. Med. 155: 1801–1807, 1995.PubMedCrossRefGoogle Scholar
  33. 33.
    Koski K., Luukinen H., Laippala P., Kivela S.L.: Physiological factors and medications as predictors of injurious falls by elderly people: a prospective population-based study. Age Ageing 25: 29–38, 1996.PubMedCrossRefGoogle Scholar
  34. 34.
    Medelson W.B.: The use of sedative/hypnotic medication and its correlation with falling down in the hospital. Sleep 19: 698–701, 1996.Google Scholar
  35. 35.
    Ranstam J., Elffors L., Kanis J.A.: A mental-functional risk score for prediction of hip fracture. Age Ageing 25: 439–442, 1996.PubMedCrossRefGoogle Scholar
  36. 36.
    Graafmans W.C., Ooms M.E., Hofstee H.M., Bezemer P.D., Bouter L.M., Lips P.: Falls in the elderly: a prospective study of risk factors and risk profiles. Am. J. Epidemiol. 143: 1129–1136, 1996.PubMedCrossRefGoogle Scholar
  37. 37.
    Neutel C.I., Hirdes J.P., Maxwell C.J., Patten S.B.: New evidence on benzodiazepine use and falls: the time factor. Age Ageing 25: 273–278, 1996.PubMedCrossRefGoogle Scholar
  38. 38.
    Stevens J.A., Powell K.E., Smith S.M., Wingo P.A., Sattin R.W.: Physical activity, functional limitations, and the risk of fall-related fractures in community-dwelling elderly. Ann. Epidemiol. 7: 54–61, 1997.PubMedCrossRefGoogle Scholar
  39. 39.
    Herndon J.G., Helmick C.G., Sattin R.W., Stevens J.A., DeVito C., Wingo P.A.: Chronic medical conditions and risk of fall injury events at home in older adults. J. Am. Geriatr. Soc. 45: 739–743, 1997.PubMedGoogle Scholar
  40. 40.
    Cumming R.G.: Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 12: 43–53, 1998.PubMedCrossRefGoogle Scholar
  41. 41.
    Turner L.W., Wang M.Q., Fu Q.: Risk factors for hip fracture among Southern older women. South Med. J. 91: 533–540, 1998.PubMedCrossRefGoogle Scholar
  42. 42.
    Koski K., Luukinen H., Laippala P., Kivela S.L.: Risk factors for major injurious falls among the home-dwelling elderly by functional abilities. A prospective population-based study. Gerontology 44: 232–238, 1998.PubMedCrossRefGoogle Scholar
  43. 43.
    Weiner D.K., Hanlon J.T., Studenski S.A.: Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 44: 217–221, 1998.PubMedCrossRefGoogle Scholar
  44. 44.
    Rubio J.I.M., Zunzunegui M.V., Beland F.: Prevalencia y factores asociados a las caìdas en las personas mayores que viven en la comunidad. Med. Clin (Barc.) 108: 128–132, 1997.Google Scholar
  45. 45.
    Ivers R.Q., Cumming R.G., Mitchell P., Attebo K.: Visual impairment and falls in older adults: The Blue Mountains Eye Study. J. Am. Geriatr. Soc. 46: 58–64, 1998.PubMedGoogle Scholar
  46. 46.
    Studenski S., Duncan P.W., Chandler J., Samsa G., Prescott B., Hogue C., Bearon L.B.: Predicting falls: the role of mobility and nonphysical factors. J. Am. Geriatr. Soc. 42: 297–302, 1994.PubMedGoogle Scholar
  47. 47.
    von Renteln-Kruse W., Micol W., Oster P., Schlierf G.: Arzneimittelverordnungen, Schwindel und Stürze bei über 75jährigen Krankenhauspatienten. Z. Gerontol. Geriatr. 31: 286–289, 1998.CrossRefGoogle Scholar
  48. 48.
    Leipzig R.M., Cumming R.G., Tinetti M.E.: Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J. Am. Geriatr. Soc. 47: 30–39, 1999.PubMedGoogle Scholar
  49. 49.
    Thapa P.B., Gideon P., Cost T.W., Milam A.B., Ray W.A.: Antidepressants and the risk of falls among nursing home residents. N. Engl. J. Med. 339: 875–882, 1998.PubMedCrossRefGoogle Scholar
  50. 50.
    Schwab M., Röder F., Mörike K., Thon, K-P., Klotz U.: Prevention of falls in elderly people. Lancet 353: 928, 1999.PubMedCrossRefGoogle Scholar
  51. 51.
    Folstein M.R., Folstein S.E., McHugh P.R.: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189–198, 1975.PubMedCrossRefGoogle Scholar
  52. 52.
    Monane M., Avorn J.: Medications and falls. Causation, correlation, and prevention. Clin. Geriatr. Med. 12: 847–858, 1996.PubMedGoogle Scholar
  53. 53.
    King M.B., Tinetti M.E.: A multifactorial approach to reducing injurious falls. Clin. Geriatr. Med. 12: 745–759, 1996.PubMedGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 2000

Authors and Affiliations

  • M. Schwab
    • 1
  • F. Röder
    • 2
  • T. Aleker
    • 3
  • S. Ammon
    • 1
  • K-P. Thon
    • 3
  • M. Eichelbaum
    • 1
  • U. Klotz
    • 1
  1. 1.Dr. Margarete Fischer-Bosch Institute of Clinical PharmacologyStuttgartGermany
  2. 2.Department of Geriatric RehabilitationRobert Bosch HospitalStuttgartGermany
  3. 3.Department of General, Abdominal and Traumatic SurgeryRobert Bosch HospitalStuttgartGermany

Personalised recommendations